Senti Biosciences, Inc.
2 additional officers and directors
Every relationship, signal and contact on this record, with the source on each.
Includes 3 days of DFX Intelligence. Then $199/month unless canceled.
What matters now
- 3 investorsnamed
3 investors on record.
The investors already on the cap table shape who leads the next round.
- 5 directorsboard
5 directors on record from Form D filings and board-seat attributions.
The board is who decides on the next round and on a sale.
Facts
Financing history
- Dec 9, 2024Form D equity offering · $37.6M (form d sold) · 15 investorsFact Form D · “Senti Biosciences, Inc. filed Form D: $37,604,250 sold of $120,594,900, Biotechnology”
Investors on record
- Lifeforce Capital Management, LLC portfolio listing Fact lifeforcecap.com
- Omega Fund Management, LLC portfolio listing Fact omegafunds.com
- Ldvp Management, LLC board only, Donald Tang (strongly supported) Inference sec.gov
Ownership and outcomes
How these are wordedA company a buyout or growth firm lists on its own site is “listed in the portfolio of”, never “acquired by”. A date prints only when a deal record gives one; otherwise the row says when DFX first saw it.Listed on 2 firm portfolio pages; none states an outcome (acquired, public, exited or active). DFX does not assume the company is active.
Evidence: 2 listingseach firm's own card, as read
- Status not stated on Lifeforce Capital Management, LLC · the firm's card prints no outcome · read Sep 13, 2026 lifeforcecap.com“senti.png”
- Status not stated on Omega Fund Management, LLC · the firm's card prints no outcome · read Sep 13, 2026 omegafunds.com“Senti Biosciences”
Credit relationships
How a loan is matchedA BDC reports its loans by borrower name. A position shows here only when the match passed a precision gate (a hand-labelled sample was 29 of 30 correct); the tier and confidence are printed on each row. Amounts are the lender’s reported position, never a round.People
- Kanya Rajangam Executive Officer sec.gov
- Timothy Lu Executive Officer/Director sec.gov
- Yvonne Li Executive Officer sec.gov
- Brenda Cooperstone Director Fact
- James Collins Director Fact
Show all 6 officers and directors
- Kanya Rajangam Executive Officer sec.gov
- Timothy Lu Executive Officer/Director sec.gov
- Yvonne Li Executive Officer sec.gov
- Brenda Cooperstone Director Fact
- James Collins Director Fact
- Donald Tang Director Inference
Timeline
- Sep 23, 2026Form 8-K filed 2026-09-24 reports the resignation of Brenda Cooperstone as director of Senti Biosciences Holdings, Inc.Director departed Fact SEC 8-K Item 5.02 officer and director…
- Dec 19, 2024Senti Biosciences, Inc. filed Form D: $37,604,250 sold of $120,594,900, BiotechnologyForm D filed Fact Form D
Evidence
Every observation on this company
- Description: Sep 22, 2026 Fact
- Entity type: Corporation Dec 19, 2024 Fact Form D
- Form D industry group: Biotechnology Dec 19, 2024 Fact Form D
- Amendment: false Dec 19, 2024 Fact Form D
- Revenue range (Form D): Decline to Disclose Dec 19, 2024 Fact Form D
- Incorporated: withinFiveYears Dec 19, 2024 Fact Form D
- Jurisdiction: Delaware Dec 19, 2024 Fact Form D
- Amount sold (Form D): $37.6M Dec 19, 2024 Fact Form D
- Offering amount (Form D): $121M Dec 19, 2024 Fact Form D
- Exemptions: 06b Dec 19, 2024 Fact Form D
- First sale: 2024-12-09 Dec 19, 2024 Fact Form D
- Investors (Form D): 15 Dec 19, 2024 Fact Form D
- Minimum investment (Form D): 0 Dec 19, 2024 Fact Form D
- Securities offered: Equity, option Dec 19, 2024 Fact Form D
- Office address: Dec 19, 2024 Fact Form D
- Listed on portfolio page: Omega Fund Management, LLC Sep 13, 2026 Fact Firm website
- Listed on portfolio page: Lifeforce Capital Management, LLC Sep 13, 2026 Fact Firm website
- Website status: ok Sep 22, 2026 Fact
- Site title: Sep 22, 2026 Fact
- Year of incorporation: 2021 Dec 19, 2024 Fact Form D
Relationships across DFX
on 1 other DFX graph
Senti Biosciences, Inc. is the same institution as 1 record in Private Equity.
The joined record opens with the product, beside every other relationship on this page.
Checking your plan…
Record history
- Event retracted2026-09-30
- Event retracted2026-09-30
- Portfolio entry removed2026-09-16source on record
+2 more changes on this record's ledger
Includes 3 days of DFX Intelligence. Then $199/month unless canceled.
The ledger records every merge, rename and reclassification this record went through and the dated filings observed on it, so the identity on this page can be traced to the records it was built from. The ledger's own sentences name other records, so they show with the names.